Results 91 to 100 of about 1,816 (199)

Ophthalmic Inserts prepared either by Extrusion or by Freeze-Drying : Technological and Biopharmaceutical Characterization [PDF]

, 2015
The main goal of this thesis is the development of an ophthalmic biodegradable insert containing fluocinolone acetonide (FA), to apply in the posterior segment of the eye. The inserts under study were prepared using the hot-melt extrusion technique (HME).
TERRENI, ELEONORA
core  

Ophtalmologie. Rétinopathie diabétique: nouvelles possibilités thérapeutiques [Diabetic retinopathy: new therapeutic possibilities]. [PDF]

, 2015
La rétinopathie diabétique touche un nombre croissant de personnes, soit quatre millions en Europe, ce chiffre va probablement doubler d'ici 2030. Si l'on considère que 25-30% de ces patients sont atteints de rétinopathie diabétique, un dépistage et un ...
Behar-Cohen, F., Guex-Crosier, Y.
core  

Intravitreal Fluocinolone Acetonide 0.19 mg Implant in a Patient with Resistant Blau Syndrome: A Case Report

Case Reports in Ophthalmology
Introduction: Blau syndrome is a progressive disease with an unknown etiology and pathogenesis. It can cause severe damage, especially in the eye with severe involvement.
Khushi Saigal, Arash Maleki
doaj   +1 more source

Intravitreal fluocinolone acetonide 0.19 mg Iluvien implant for radiation maculopathy

Canadian Journal of Ophthalmology
To evaluate the efficacy of a long-acting fluocinolone acetonide 0.19 mg Iluvien intravitreal (FAc) implant for the treatment of radiation maculopathy (RM).Retrospective case series.Seven patients treated for uveal melanoma with palladium-103 plaque brachytherapy who developed RM.Patients initially received intravitreal anti-vascular endothelial growth
Paul T. Finger, Shayri Pillai, Ankit Singh Tomar   +2 more
openaire   +2 more sources

Use of intravitreal fluocinolone acetonide implant in inflammatory macular oedema

Eye
Abstract Background/objectives To assess the effectiveness and safety of 0.19-mg fluocinolone acetonide implant (FAc-implant) in inflammatory macular oedema (MO). Subjects/methods This observational, retrospective ...
Chloé Gullon, Sandra Elbany, Nicolas Romain-Scelle, Carole Burillon, Corinne Dot, Thibaud Mathis, Yasmine Serrar, Mariam Ghazaryan, François Devin, Laurent Kodjikian   +9 more
openaire   +1 more source

Clinical utility of intravitreal fluocinolone acetonide (Iluvien®) implant in the management of patients with chronic diabetic macular edema: a review of the current literature

Clinical Ophthalmology, 2017
Habiba Saedon,1 Astha Anand,1 Yit C Yang1,2 1Department of Ophthalmology, Royal Wolverhampton NHS Trust, Wolverhampton, West Midlands, 2School of Life and Health Sciences, Aston University, Birmingham, UK Abstract: The first-line therapy for patients ...
Saedon H, Anand A, Yang YC
doaj  

Efficacy and Safety of Fluocinolone Acetonide Implant in Diabetic Macular Edema: Practical Guidelines from Reference Center

Pharmaceutics
Diabetic macular edema (DME) is a common complication of diabetic retinopathy. Treatment with intravitreal injections is effective in most cases but is associated with a high therapeutic burden for patients. This implies the need for long-term treatments,
Lucas Sejournet, Thibaud Mathis, Victor Vermot-Desroches, Rita Serra, Ines Fenniri, Philippe Denis, Laurent Kodjikian   +6 more
doaj   +1 more source

Optical Coherence Tomography Biomarkers of Inflammation in Diabetic Macular Edema Treated by Fluocinolone Acetonide Intravitreal Drug-Delivery System Implant

Ophthalmology and Therapy, 2020
Introduction The fluocinolone acetonide (FAc) intravitreal drug-delivery system implant is a recent, second-line, intravitreal drug for the management of diabetic macular edema (DME). FAc acts against DME with a major anti-inflammatory effect.
Alessandro Arrigo, Luigi Capone, Rosangela Lattanzio, Emanuela Aragona, Piero Zollet, Francesco Bandello   +5 more
doaj   +1 more source

Punctate Inner Choroidopathy: A Review [PDF]

, 2016
Punctate Inner Choroidopathy (PIC), an idiopathic inflammatory multifocal chorioretinopathy that predominantly affects young myopic women, appears to be relatively rare, but there is limited data to support accurate estimates of prevalence, and it is ...
Ahnood, D, Denniston, AK, Keane, PA, Madhusudhan, S, Tsaloumas, MD, Waheed, NK   +5 more
core  

Clinical utility of intravitreal fluocinolone acetonide (Iluvien®) implant in the management of patients with chronic diabetic macular edema:a review of the current literature [PDF]

, 2017
The first-line therapy for patients with center-involving diabetic macular edema (DME) is with intravitreal anti-vascular endothelial growth factor (VEGF) agents, with or without adjunctive macular laser treatment.
Anand, Astha, Saedon, Habiba, Yit, Yang C.   +2 more
core   +2 more sources